loading animation for AJAX calls

176 Reports in Pharmaceuticals

Global Markets for Infectious Disease Treatments

Published - Jan 2016 | Analyst - Peggy Lehr| Code - PHM061C

The global market for infectious disease diagnostic, vaccine, and treatment products reached $108.4 billion in 2015. The market should reach $126.2 billion in 2016 and $183.2 billion in 2021, demonstrating a compound annual growth rate (CAGR) of 7.7% from 2016 to 2021.

Global Markets for Orphan Drugs

Published - Sep 2015 | Analyst - Shalini Shahani Dewan| Code - PHM038E

The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019, demonstrating a compound annual growth rate (CAGR) of 9.2% during the forecast period (2014 to 2019).

Ophthalmic Therapeutic Drugs: Technologies and Global Markets

Published - Jul 2015 | Analyst - Dr. Cheryl Lee Barton| Code - PHM031D

The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2019, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2019.

Global Markets for Contract Pharmaceutical Manufacturing, Researc...

Published - Jun 2015 | Analyst - Shalini Shahani Dewan| Code - PHM043F

The global market for contract pharmaceutical manufacturing, research and packaging totaled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.

Liver Disease Treatments: The Global Market

Published - Jun 2015 | Analyst - Yogita Zutshi| Code - PHM057C

The global liver diseases therapeutics market totaled nearly $24.5 billion in 2014 and is projected to approach $33.8 billion by 2019, registering a compound annual growth rate (CAGR) of 6.7% through 2019.

Diagnostics and Therapeutics for Lung Cancer: Global Markets

Published - May 2015 | Analyst - Vijay Laxmi| Code - PHM174A

The global market for lung cancer grew to $21.9 billion in 2014 from $20.3 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 7.8% from 2014 to 2019, totaling $31.8 billion in 2019.

Regenerative Medicines: Bone and Joint Applications

Published - May 2015 | Analyst - Kevin Gainer| Code - PHM032D

The U.S. market for regenerative medicine products used in bone and joint applications is expected to grow at a compound annual growth rate (CAGR) of 6.8% from $2.9 billion in 2015 to nearly $4.1 billion in 2020.

Drug Testing: Technologies and Global Markets

Published - Mar 2015 | Analyst - Jon Evans| Code - PHM013F

The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.

Incretin-Based Drugs: Markets for Diabetes Therapies and Developi...

Published - Feb 2015 | Analyst - Kim Lawson| Code - PHM162A

The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a compound annual growth rate (CAGR) of 12.4% from 2014 to 2019.

Therapeutics for 'Silent' Cancers

Published - Feb 2015 | Analyst - Paul Evers| Code - PHM169A

The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.

Global Markets for Allergy Diagnostics and Treatments

Published - Feb 2015 | Analyst - Peggy Lehr| Code - PHM026B

Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.

Global Markets for Drug-Device Combinations

Published - Jan 2015 | Analyst - Kevin Gainer| Code - PHM045D

The sales of drug-device combination products reached $21.4 billion in 2013 and $22 billion in 2014. This market is expected to grow to $31 billion in 2019, with a compound annual growth rate (CAGR) of 7.1% from 2014 to 2019.

Cancer Vaccines: Technologies and Global Markets

Published - Jan 2015 | Analyst - Shalini Shahani Dewan| Code - PHM173A

The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019.

Pediatric Medicines: Global Markets

Published - Oct 2014 | Analyst - Dr. Cheryl Lee Barton| Code - PHM170A

The global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.

Radiopharmaceuticals: Technologies and Global Markets

Published - Sep 2014 | Analyst - Shalini Shahani Dewan| Code - PHM171A

The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.

Autoimmune Disease Diagnostics: Global Markets

Published - Sep 2014 | Analyst - Anandi Karumbati| Code - PHM160A

The global market value for autoimmune disease diagnostics for 2013 was valued at $11.9 billion. This is expected to reach about $12.1 billion in 2014 and $13.1 billion in 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019.

Blood-Brain Barrier Technologies and Global Markets

Published - Jul 2014 | Analyst - Kim Lawson| Code - PHM075B

The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.

Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Glo...

Published - Jun 2014 | Analyst - Yogita Zutshi| Code - PHM069B

The global market for Multiple Sclerosis (MS) disease-modifying products reached $10.1 billion in 2012 and nearly $10.9 billion in 2013. This market is expected to grow to nearly $14.2 billion in 2018 with a compound annual growth rate (CAGR) of 5.4% over the five-year period from 2013 to 2018.

Antifungal Drugs: Technologies and Global Markets

Published - Jun 2014 | Analyst - Mary Anne Crandall| Code - PHM029E

The global market for human antifungal therapeutics reached nearly $11.6 billion in 2012 and $11.8 billion in 2013. This market is expected to grow to nearly $13.9 billion in 2018 with a compound annual growth rate (CAGR) of 3.2% over the five-year period from 2013 to 2018.

Markets for Advanced Wound Management Technologies

Published - Jun 2014 | Analyst - Melissa Elder| Code - PHM011H

The global market for advanced wound management totaled $8.6 billion in 2013, up from 2011’s value of $7.9 billion. By 2018, this market is likely to reach $11.3 billion, a compound annual growth rate (CAGR) of 5.6%.

Antibiotics: Technologies and Global Markets

Published - May 2014 | Analyst - Neha Maliwal| Code - PHM025C

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.

JAK and PI3K Signaling Pathway Markets

Published - Apr 2014 | Analyst - Shalini Shahani Dewan| Code - PHM168A

The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.

Diagnostics and Therapeutics for HIV: Global Markets

Published - Apr 2014 | Analyst - Kritika Chaudhari| Code - PHM058B

The global market for HIV therapeutics is expected to grow to $18.2 billion in 2013 and $19.6 in 2018, with a compound annual growth rate (CAGR) of 1.5%.

Drugs for Treating Systemic Lupus Erythematosus: Global Markets

Published - Mar 2014 | Analyst - Sanjukta Bhattacharyya| Code - PHM159A

The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.

Cancer Immunology and Oncolytic Virology: Technologies and Global...

Published - Mar 2014 | Analyst - Valerie Kellogg| Code - PHM129A

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018.

« 2 3 4 5 6 »

6 Upcoming Reports in Pharmaceuticals

Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppression, That is the Question

Target Date - May 2019| Author - Dr. Cheryl Lee Barton| Code - PHM212A| Price - $995

Report Includes

  • An introduction to interleukin-2 (IL-2) and identification of its applications
  • Insights of the latest trends and technologies in the IL-2 research and development
  • Discussion of strategies adopted by IL-2 developers for the successful treatment of cancer and information on NKTR-214, a Nektar Therapeutics product
  • Review of recent VC investment in this zone highlighted by Syncona and Novartis Venture Fund recent CHF35m investment in Anaveon AG, a new Swiss Biotech company spun out from the University of Zuirich which is developing a novel oncologic monoclonal antibody that boosts IL-2 but has an improved side-effect profile.
  • Detailed description of autoimmune responses and possible ways to augment immune responses so as to improve antitumor activity and reduce off target effect
  • An understanding of various conditions which may develop as an off-target effects in the cancer treatment such as metastatic melanoma (MM), renal cell carcinoma (RCC), urothelial cancers (US) relapse remitting multiple sclerosis (RRMS), and Type 1 diabetes (T1D)

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM